Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cellular and Molecular Life Sciences

• Publication date

  2017-10-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00018-017-2681-zPMID 29071385PMCID PMC7984729
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bladder cancer

  2020cited by this paper
• Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics

  2017cited by this paper
• Urinary Bladder Cancer: Biomarkers and Target Therapy, New Era for More Attention

  2016cited by this paper
• Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword

  2016cited by this paper
• Protein Kinase D Enzymes as Regulators of EMT and Cancer Cell Invasion

  2016cited by this paper
• Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach

  2016cited by this paper
• limma powers differential expression analyses for RNA-sequencing and microarray studies

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Global Cancer Incidence and Mortality Rates and Trends—An Update

  2015cited by this paper
• Protein kinase D2 contributes to TNF-α-induced epithelial mesenchymal transition and invasion via the PI3K/GSK-3β/β-catenin pathway in hepatocellular carcinoma

  2015cited by this paper
• Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation

  2015cited by this paper
• Protein kinase D2 silencing reduced motility of doxorubicin-resistant MCF7 cells

  2015cited by this paper
• Effective Targeting of Estrogen Receptor–Negative Breast Cancers with the Protein Kinase D Inhibitor CRT0066101

  2015cited by this paper
• Protein kinase D enzymes: novel kinase targets in pancreatic cancer

  2015cited by this paper
• Comprehensive molecular characterization of urothelial bladder carcinoma

  2014cited by this paper
• Advances in intravesical therapy for the treatment of non-muscle invasive bladder cancer (Review).

  2014cited by this paper
• The cytotoxic effects of regorafenib in combination with protein kinase D inhibition in human colorectal cancer cells

  2014cited by this paper
• Roles of Chk1 in cell biology and cancer therapy

  2014cited by this paper
• Protein Kinase D as a Potential Chemotherapeutic Target for Colorectal Cancer

  2014cited by this paper
• PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis.

  2014cited by this paper
• β-Elemene promotes cisplatin-induced cell death in human bladder cancer and other carcinomas.

  2013cited by this paper
• Protein kinases D2 and D3 are novel growth regulators in HCC1806 triple-negative breast cancer cells.

  2013cited by this paper
• Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro

  2013cited by this paper
• PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-&kgr;B- and HDAC1-mediated expression and activation of uPA

  2012cited by this paper
• The influence of reactive oxygen species on cell cycle progression in mammalian cells.

  2012cited by this paper
• Protein Kinase D1 Maintains the Epithelial Phenotype by Inducing a DNA-Bound, Inactive SNAI1 Transcriptional Repressor Complex

  2012cited by this paper
• New therapeutic challenges in advanced bladder cancer.

  2012cited by this paper
• Metastatic Bladder Cancer: A Review of Current Management

  2011cited by this paper
• Cdc2: a monopotent or pluripotent CDK?

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth In vitro and In vivo

  2010cited by this paper
• Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1 and p57Kip2 CDK inhibitors

  2010cited by this paper
• Emerging targeted therapies for bladder cancer: a disease waiting for a drug

  2009cited by this paper
• Bladder cancer

  2009cited by this paper
• Protein Kinase D-dependent Phosphorylation and Nuclear Export of Histone Deacetylase 5 Mediates Vascular Endothelial Growth Factor-induced Gene Expression and Angiogenesis*

  2008cited by this paper
• Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

  2006cited by this paper
• Bladder cancer outcome and subtype classification by gene expression.

  2006cited by this paper
• Protein Kinase C-dependent Protein Kinase D Activation Modulates ERK Signal Pathway and Endothelial Cell Proliferation by Vascular Endothelial Growth Factor*

  2005cited by this paper
• Bladder Cancer Outcome and Subtype Classification by Gene Expression

  2005cited by this paper
• Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor–induced Nur77 expression and apoptosis

  2005cited by this paper
• Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIβ at the Golgi complex

  2005cited by this paper
• Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIbeta at the Golgi complex.

  2005cited by this paper
• Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.

  2005cited by this paper
• Cell Cycle Checkpoint Proteins and Cellular Response to Treatment by Anticancer Agents

  2004cited by this paper
• G2 checkpoint abrogators as anticancer drugs.

  2004cited by this paper
• A novel synthetic inhibitor of CDC25 phosphatases: BN82002.

  2004cited by this paper
• Gene Expression in the Urinary Bladder

  2004cited by this paper
• p53 protein variants: structural and functional similarities with p63 and p73 isoforms

  2004cited by this paper
• Cell cycle checkpoints and their impact on anticancer therapeutic strategies

  2004cited by this paper
• Regulation of Cdc25C Activity During the Meiotic G2/M Transition

  2004cited by this paper
• Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis.

  2004cited by this paper
• Regulation of Chk1 Includes Chromatin Association and 14-3-3 Binding following Phosphorylation on Ser-345*

  2003cited by this paper
• Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

  2003cited by this paper
• GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress

  2002cited by this paper
• 14-3-3 binding regulates catalytic activity of human Wee1 kinase.

  2001cited by this paper
• Tetra-O-methyl nordihydroguaiaretic acid induces G2 arrest in mammalian cells and exhibits tumoricidal activity in vivo.

  2001cited by this paper
• Positive regulation of Wee1 by Chk1 and 14-3-3 proteins.

  2001cited by this paper
• Role of Diacylglycerol in PKD Recruitment to the TGN and Protein Transport to the Plasma Membrane

  2001cited by this paper
• Binding of 14-3-3beta to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2-M cell population.

  2000cited by this paper
• p53‐independent Induction of p21 (WAF1/CIP1), Reduction of Cyclin B1 and G2/M Arrest by the Isoflavone Genistein in Human Prostate Carcinoma Cells

  2000cited by this paper
• The G2-phase DNA-damage checkpoint.

  2000cited by this paper
• Oxidative Stress Induces Protein Kinase D Activation in Intact Cells

  2000cited by this paper
• Cell cycle control as a basis for cancer drug development (Review).

  2000cited by this paper
• Nuclear Import of Cdk/Cyclin Complexes: Identification of Distinct Mechanisms for Import of Cdk2/Cyclin E and Cdc2/Cyclin B1

  1999cited by this paper
• GADD45 induction of a G2/M cell cycle checkpoint.

  1999cited by this paper
• Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein

  1999cited by this paper
• Ran-independent nuclear import of cyclin B1-Cdc2 by importin beta.

  1999cited by this paper
• Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45

  1999cited by this paper
• Cdc25 protein phosphatases in cell proliferation.

  1997cited by this paper
• Regulation of transcription by proteins that control the cell cycle

  1997cited by this paper
• Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase.

  1997cited by this paper
• Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25.

  1997cited by this paper
• 14-3-3sigma is a p53-regulated inhibitor of G2/M progression.

  1997cited by this paper
• 14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression

  1997cited by this paper
• Protein kinase D (PKD) activation in intact cells through a protein kinase C‐dependent signal transduction pathway.

  1996cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• The Wee1 protein kinase regulates T14 phosphorylation of fission yeast Cdc2.

  1995cited by this paper
• Identification of a 95-kDa WEE1-like tyrosine kinase in HeLa cells.

  1995cited by this paper
• Regulation of the human WEE1Hu CDK tyrosine 15‐kinase during the cell cycle.

  1995cited by this paper
• Myt1: A Membrane-Associated Inhibitory Kinase That Phosphorylates Cdc2 on Both Threonine-14 and Tyrosine-15

  1995cited by this paper
• Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase.

  1993cited by this paper

• Airborne polystyrene nanoplastic exposure leads to splenic cell senescence and immune imbalance.

  2026cites this paper
• Golgi Drivers of Cancer.

  2026cites this paper
• Deciphering the transcriptional alterations in high grade serous ovarian cancer upon catalytic inactivation of protein kinase D.

  2025cites this paper
• Effect of PRKD3 on cell cycle in gastric cancer progression and downstream regulatory networks

  2025cites this paper
• Deciphering the transcriptional alterations in high grade serous ovarian cancer upon catalytic inactivation of protein kinase D.

  2025cites this paper
• Interactions between lncRNAs and cyclins/CDKs complexes; key players in determining cancer cell response to CDKs inhibitors.

  2025cites this paper
• Deoxybouvardin Glucoside Induces Apoptosis in Oxaliplatin-Sensitive and -Resistant Colorectal Cancer Cells via Reactive Oxygen Species-Mediated Activation of JNK and p38 MAPK

  2025cites this paper
• Targeting adipocyte differentiation with CRT0066101: activation of AMPK signaling in 3T3-L1 cells

  2025cites this paper
• Discovery of anticancer function of Febrifugine: Inhibition of cell proliferation, induction of apoptosis and suppression steroid synthesis in bladder cancer cells.

  2024cites this paper
• TSG101 overexpression enhances metastasis in oral squamous cell carcinoma through cell cycle regulation.

  2024cites this paper
• PKD regulates mitophagy to prevent oxidative stress and mitochondrial dysfunction during mouse oocyte maturation.

  2024cites this paper
• Pharmacological inhibition of protein kinase D2/Aurora kinase A signalling axis suppresses G2/M cell cycle progression and proliferation of epithelial ovarian cancer cells.

  2024cites this paper
• Cepharanthine inhibits migration, invasion, and EMT of bladder cancer cells by activating the Rap1 signaling pathway in vitro.

  2024cites this paper
• PKCμ promotes keratinocyte cell migration through Cx43 phosphorylation-mediated suppression of intercellular communication

  2024cites this paper
• Protein kinase D2 and 3 promote prostate cancer cell bone metastasis by positively regulating Runx2 in a MEK/ERK1/2-dependent manner.

  2023cites this paper
• The Golgi Apparatus as an Anticancer Therapeutic Target

  2023cites this paper
• Protein kinase D1 - A targetable mediator of pancreatic cancer development.

  2023cites this paper
• Protein kinase D activity is a risk biomarker in prostate cancer that drives cell invasion by a snail/ERK dependent mechanism.

  2023cites this paper
• Pharmacological inhibition of protein kinase D suppresses epithelial ovarian cancer via MAPK/ERK1/2/Runx2 signalling axis.

  2023cites this paper
• Endothelial Protein kinase D1 is a major regulator of post-traumatic hyperinflammation

  2023cites this paper
• Potential role for protein kinase D inhibitors in prostate cancer

  2023cites this paper
• Estrogen receptor alpha mutations regulate gene expression and cell growth in breast cancer through microRNAs

  2023cites this paper
• A Protein Kinase D Inhibitor Suppresses AKT on T cells and Antagonizes Cancer Immunotherapy by Anti-PD-1.

  2022cites this paper
• Protein kinase D promotes prostate cancer cell bone metastasis by positively regulating Runx2 in a MEK/ERK1/2-dependent manner

  2022cites this paper
• NEAT1/MALAT1/XIST/PKD--Hsa-Mir-101-3p--DLGAP5 Axis as a Novel Diagnostic and Prognostic Biomarker Associated With Immune Cell Infiltration in Bladder Cancer

  2022cites this paper
• A review on the role of cyclin dependent kinases in cancers

  2022cites this paper
• Small Molecule Inhibitors of Protein Kinase D: Early Development, Current Approaches, and Future Directions.

  2022cites this paper
• Oxocrebanine: A Novel Dual Topoisomerase inhibitor, Suppressed the Proliferation of Breast Cancer Cells MCF-7 by Inducing DNA Damage and Mitotic Arrest.

  2021cites this paper
• ERK knockdown suppress cell biological activities via regulation CD59 in breast cancer

  2021cites this paper
• Small-Molecule Inhibitor Targeting Protein Kinase D: A Potential Therapeutic Strategy

  2021influential citation
• Reduced kinase D‑interacting substrate of 220 kDa (Kidins220) in pancreatic cancer promotes EGFR/ERK signalling and disease progression.

  2021cites this paper
• Protein Kinase D2 drives chylomicron‐mediated lipid transport in the intestine and promotes obesity

  2021cites this paper
• Developments in the Discovery and Design of Protein Kinase D Inhibitors

  2021cites this paper
• Multifaceted Functions of Protein Kinase D in Pathological Processes and Human Diseases

  2021cites this paper
• Anthraquinone derivative C10 inhibits proliferation and cell cycle progression in colon cancer cells via the Jak2/Stat3 signaling pathway.

  2021cites this paper
• The role of protein kinase D (PKD) in intracellular nutrient sensing and regulation of adaptive responses to the obese environment

  2020cites this paper
• Sulforaphane Reduces Prostate Cancer Cell Growth and Proliferation In Vitro by Modulating the Cdk-Cyclin Axis and Expression of the CD44 Variants 4, 5, and 7

  2020influential citation
• Comprehensively investigating the expression levels and the prognostic role of transforming growth factor beta-induced (TGFBI) in glioblastoma multiforme

  2020cites this paper
• ROS-mediated genotoxic stress is involved in NaAsO2-induced cell cycle arrest, stemness enhancement and chemoresistance of prostate cancer cells in a p53-independent manner.

  2020cites this paper
• Reactive oxygen species-mediated cellular genotoxic stress is involved in 1-nitropyrene-induced trophoblast cycle arrest and fetal growth restriction.

  2020cites this paper
• Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c‐MYC axis in breast cancer

  2020cites this paper
• Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment

  2019cites this paper
• Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro

  2019cites this paper
• The Role and Mechanism of CRT 0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer

  2019cites this paper
• Deciphering the Role of Protein Kinase D1 (PKD1) in Cellular Proliferation

  2019cites this paper
• Inhibition of protein kinase D disrupts spindle formation and actin assembly during porcine oocyte maturation

  2018cites this paper
• Protein Kinase D2 Modulates Cell Cycle By Stabilizing Aurora A Kinase at Centrosomes

  2018cites this paper
• Identification of key genes and pathways in human glioblastoma multiforme by co-expression analysis

  2018cites this paper
• Clinical value and potential pathways of miR-183-5p in bladder cancer: A study based on miRNA-seq data and bioinformatics analysis.

  2018cites this paper
• Protein kinase D1: gatekeeper of the epithelial phenotype and key regulator of cancer metastasis?

  2018cites this paper
• Antitumor activity of the microtubule inhibitor MBRI-001 against human hepatocellular carcinoma as monotherapy or in combination with sorafenib

  2018cites this paper
• ERK knockdown suppresses cell biological activities via regulation of CD59 in breast cancer

  year unknowncites this paper